News

CME Group and FTSE Russell Partnership: A Commitment to Clients

CME Group and FTSE Russell Partnership: A Commitment to Clients

CME Group and FTSE Russell Extend Their Collaboration

Today, CME Group, a global leader in derivatives trading, has announced a significant 12-year extension of its licensing agreement with FTSE Russell, a prominent provider of indices worldwide. This partnership allows CME Group to continue offering an extensive range of futures and options on futures, along with OTC-cleared products that are based on various FTSE Russell indexes. The agreement is aimed at providing robust tools for market participants to effectively manage equity index exposure.

The Benefits of the Extended Licensing Agreement

Tim McCourt, the Global Head of Equities, FX and Alternative Products at CME Group, expressed enthusiasm about the extended partnership. He highlighted that over the years, their collaboration has grown remarkably, leading to enhanced liquidity and efficiency for clients trading in the equity space. This extension reinforces their mutual objective of delivering valuable solutions that cater to the needs of the global investment community.

Insights from FTSE Russell

Fiona Bassett, CEO of FTSE Russell, shared her excitement about the continued partnership. She emphasized the importance of their joint commitment to providing transparent index-based solutions. The growth in trading volumes associated with FTSE Russell-linked products showcases the lasting value these indices bring to investors aiming to track performance in the vast expanse of the global equity market.

The Range of Products Available

CME Group's offerings include a diverse array of futures on the Russell family indices such as Russell 1000, Russell 2000, and their respective growth and value variants. Moreover, they provide futures on FTSE indexes that cover emerging markets, developed European markets, and more. Since the inception of the previous license agreement in 2015, trading numbers have been impressive, with over 573 million contracts involving FTSE Russell indexes being exchanged.

Significant Volume Growth

Current figures indicate that the average daily trading volume in the Russell futures and options complex has reached 306,000 contracts this year alone, reflecting a healthy and thriving marketplace. This kind of trading activity highlights the increasing reliance on these instruments by market participants looking to capitalize on index movements.

About CME Group and Its Offerings

CME Group operates as a leading marketplace for derivatives, enabling clients to engage in a wide range of trading activities. The organization offers diverse trading solutions covering various asset classes including interest rates, equity indexes, foreign exchange, cryptocurrencies, energy, agricultural products, and metals. Utilizing the CME Globex platform, clients can efficiently trade futures and options across global markets while effectively managing risk.

Exploring the Future with FTSE Russell

FTSE Russell stands at the forefront of index provision, delivering innovative index analytics and solutions for investors across the globe. It manages thousands of indexes that provide benchmarks for evaluating markets and asset classes in over 70 countries, capturing an incredible 98% of the global investable market. With approximately $18.1 trillion being benchmarked to FTSE Russell indexes, it’s clear that extensive reliance is placed on their offerings.

High Standards in Index Design

FTSE Russell adheres to rigorous industry principles in index design and governance, utilizing a rules-based methodology guided by expert committees. Their emphasis on transparency, innovative practices, and partnerships with clients ensures that they remain a leader in the index domain while setting a high standard for the industry.

Frequently Asked Questions

What is the significance of the CME Group and FTSE Russell partnership?

The partnership allows CME Group to provide extensive derivatives products based on FTSE Russell indexes, enhancing tools for managing equity index exposure.

How long is the extension of the licensing agreement?

The licensing agreement has been extended for an additional 12 years between CME Group and FTSE Russell.

What types of products does CME Group offer related to FTSE Russell?

CME Group offers futures and options on various FTSE Russell indexes, including family indices like Russell 1000 and Russell 2000.

What are the recent trading volume statistics?

This year, the average daily volume across the Russell futures and options complex is reported at 306,000 contracts.

How much capital is benchmarked using FTSE Russell indexes?

Approximately $18.1 trillion in global assets are benchmarked against FTSE Russell indexes, showcasing their wide influence.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 176

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 221

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading
ASTS Faces Class Action; Investors Beware of Pitfalls

Updated Category News Views 183

Securities Fraud Allegations Hit AST SpaceMobile Days like this remind me why we keep our eyes peeled in the stock game—AST SpaceMobile (NASDAQ: ASTS) is tangled in a web of legal drama, and it's something you can't brush off with a shrug. Class action lawsuits for securities fraud? That's like finding out the foundation's shaky beneath a skyscraper. If you've got skin...

Continue Reading
Cleaner Air in Bedroom May Stabilize Blood Sugar Levels

Updated Category News Views 256

Imagine a world where simply sleeping in cleaner air could affect your blood sugar. Seems far-fetched, I know. But that's where we're at with this new study out of NYU Langone Health. They're talking about using plain ol' portable air filters to help steady blood sugar levels for folks dealing with prediabetes. Turns out a cleaner bedroom might just hold the key to taming...

Continue Reading
Gildan's Crisis: Investors Face Losses Amid Lawsuit

Updated Category News Views 150

Gildan Investors, Brace Yourself Poor old Gildan Activewear finds itself in hot water again, with a class action lawsuit cropping up like an unexpected storm on farmers' day. Any traders remotely involved with NYSE:GIL should pay damn close attention, because with a December 14, 2026 deadline looming, it's crunch time. The Root of the Lawsuit The plot thickens here,...

Continue Reading
Webull Faces Class Action Suit: Key Deadlines Loom

Updated Category News Views 140

The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....

Continue Reading
Quantum Space Joins $185M NASA Lunar Transport Deal

Updated Category News Views 863

Quantum Space Bags a Chunk of NASA's Lunar Ambitions Alright, folks, buckle up because we're about to dive into the cosmos. Quantum Space just nabbed a sweet deal—a $185 million whopper of a contract from NASA's Moon Base Transportation program. This isn't chump change; it's a 25% slice for Quantum from the lot Arrow Science and Technology is heading. We're talking...

Continue Reading
MWC26 Doha: Bridging Standards for MENA's Future

Updated Category News Views 437

MWC26 Doha Launches with a Connectivity Mission Forget corporate boardrooms; the real action this week is unfolding in Doha's bustling exhibition halls. Kicked off with the fanfare you'd expect from such a key event, MWC26 Doha has drawn a crowd that's got both tech geeks and policy wonks nodding with interest. This ain’t your average trade show: it’s the melting pot...

Continue Reading
Fibocom LTE Modules Test Drive Satellite Connectivity

Updated Category News Views 63

Boosting IoT with Satellite Connectivity Here's a good one for folks watching the edge of wireless innovation. Fibocom's LTE Cat.1 bis modules, the LE270-EU and LE271-GL, just stretched their legs in New Zealand, connecting seamlessly with SpaceX's Direct to Cell (DTC) satellite system. No fancy hardware swaps, just standard firmware strutting its stuff across satellite...

Continue Reading
TCL's Display Future: AI Meets Screens at DTC 2026

Updated Category News Views 578

Exploring New Horizons in Display Technology There's something brewing in Wuhan: a conference that’s shaping up like a tech enthusiast’s dream. This year, it's all about the symbiosis of cutting-edge tech and dazzling visuals as TCL CSOT gears up to unveil advancements at the Global Display Tech-Ecosystem Conference (DTC) 2026. If you're wondering whether this event...

Continue Reading

Top 5 Most Recently Viewed Articles

Market Response to Aluminium Tariff Threats and Implications

Updated Category News Views 121

Market Insights on Aluminium Pricing and Tariffs The aluminium market has been under scrutiny as recent events unfold regarding potential tariffs on Canadian imports. Despite rising aluminium prices for U.S. consumers since the presidential election, the increase has remained relatively moderate. This suggests that industry players are not overly concerned about the...

Continue Reading
Understanding the Booming Healthcare Asset Management Market

Updated Category News Views 230

Healthcare Asset Management Market Overview The Healthcare Asset Management market has been experiencing remarkable growth, with projections estimating its value to exceed USD 166.82 billion. This rapid expansion is driven by an impressive compound annual growth rate (CAGR) of 23.1% from 2024 to 2032. This article delves into the reasons behind this growth and what the...

Continue Reading
T1 Energy Inc. Faces Shareholder Investigation: What You Need to Know

Updated Category News Views 454

Understanding the Investigation of T1 Energy Inc. T1 Energy Inc. (NYSE: TE) is currently the focus of an important investigation launched by Purcell & Lefkowitz LLP, aimed at safeguarding the rights of its shareholders. This inquiry is centered on whether the directors have acted in accordance with their fiduciary duties regarding significant recent corporate actions. Why...

Continue Reading
Kimberly-Clark's Strategic Move to Shape Health and Wellness Market

Updated Category News Views 183

Kimberly-Clark's Transformative Acquisition In a remarkable move to bolster its position in the personal care products sector, Kimberly-Clark Corporation is poised to acquire Kenvue. This acquisition will create a formidable entity within the health and wellness market, valued at an impressive $32 billion. Kimberly-Clark, recognized for its commitment to sustainability...

Continue Reading
ADC Therapeutics Welcomes New Talent with Employee Grants

Updated Category News Views 106

ADC Therapeutics Expands Team with New Inducement Grant ADC Therapeutics SA (NYSE: ADCT), a leader in the field of antibody drug conjugates (ADCs), recently made headlines by offering a grant of options to acquire 6,000 of the company's common shares to a newly hired employee. This strategic move highlights the company's commitment to attracting top talent essential for...

Continue Reading